메뉴 건너뛰기




Volumn 3, Issue 11-12, 2011, Pages 798-805

Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application

Author keywords

Biosimilar; Doping; Epoetin kappa; Erythropoietin; Isoelectric focusing; Mass spectrometry; SDS PAGE

Indexed keywords

ELECTROPHORESIS; ELECTROSPRAY IONIZATION; SODIUM COMPOUNDS; SULFUR COMPOUNDS;

EID: 84855220182     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.369     Document Type: Article
Times cited : (15)

References (34)
  • 7
    • 85153151310 scopus 로고    scopus 로고
    • WADA. The 2011 Prohibited List. Available at: [17 May].
    • WADA. The 2011 Prohibited List. Available at: [17 May 2011].
    • (2011)
  • 18
    • 85153142255 scopus 로고    scopus 로고
    • WADA. Technical Document-TD2009EPO ver. 2.0. Available at: [17 May].
    • WADA. Technical Document-TD2009EPO ver. 2.0. Available at: [17 May 2011].
    • (2011)
  • 19
    • 77953674493 scopus 로고    scopus 로고
    • Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke). Sportverlag Strauß, Köln
    • P. Desharnais, C. Ayotte, in Recent Advances in Doping Analysis (15), (Eds: W. Schänzer, H. Geyer, A. Gotzmann, U. Mareck-Engelke ). Sportverlag Strauß, Köln, 2007, p. 303.
    • (2007) Recent Advances in Doping Analysis (15) , pp. 303
    • Desharnais, P.1    Ayotte, C.2
  • 29
    • 85153160179 scopus 로고    scopus 로고
    • Drug Interview Form , 873999, Japan Chemical Research Pharmaceuticals Co., Ltd.
    • Drug Interview Form 2010, 873999, Japan Chemical Research Pharmaceuticals Co., Ltd.
    • (2010)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.